Epilepsy Trial, Recruiting NCT06695767 Sponsor: The University of Texas Health Science Center, Houston Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT06695767
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are veterans and speak English
  • People who have home internet access
  • People who use a computer or tablet at least once a week and are comfortable doing so
  • People who do not currently have symptoms from their long-term health condition(s)
  • People who have a mobile phone that can send and receive text messages and photos
  • People who have been formally diagnosed with major depressive disorder (a type of serious depression)
  • People who have been formally diagnosed with epilepsy and have had at least one seizure recorded in the last five years

Who may not be able to join:

  • People who are currently pregnant
  • Veterans who are currently having thoughts of suicide
  • People who are currently experiencing psychosis (a condition that can cause a loss of touch with reality)
  • People who have been diagnosed with psychogenic non-epileptic seizures or conversion disorder (conditions where seizure-like episodes are not caused by epilepsy) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Melissa Fadipe, MSN, APRN, FNP-C, The University of Texas Health Science Center, Houston

Phone: (713) 825-7237

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 December 2024
Est. completion
6 February 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Enrollment rate; Retention rate; Session attendance rate (proportion of sessions attended); Homework completion rate (proportion of homework assignments completed); User satisfaction as assessed by The Participant Satisfaction Survey

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov